- Tytuł:
- Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant
- Autorzy:
- Źródło:
- In American Journal of Transplantation November 2019 19(11):3035-3045
Czasopismo naukowe